csirt@kutim:~/threat-intel/cve/CVE-2021-37657

Katalog CVE

CVSS 7.8 · High EPSS 0,17%

Kerentanan Access of Uninitialized Pointer pada google tensorflow. Skor CVSS 3.1 7.8 (High) menurut NVD.

Deskripsi (NVD)

TensorFlow is an end-to-end open source platform for machine learning. In affected versions an attacker can cause undefined behavior via binding a reference to null pointer in all operations of type `tf.raw_ops.MatrixDiagV*`. The [implementation](https://github.com/tensorflow/tensorflow/blob/84d053187cb80d975ef2b9684d4b61981bca0c41/tensorflow/core/kernels/linalg/matrix_diag_op.cc) has incomplete validation that the value of `k` is a valid tensor. We have check that this value is either a scalar or a vector, but there is no check for the number of elements. If this is an empty tensor, then code that accesses the first element of the tensor is wrong. We have patched the issue in GitHub commit f2a673bd34f0d64b8e40a551ac78989d16daad09. The fix will be included in TensorFlow 2.6.0. We will also cherrypick this commit on TensorFlow 2.5.1, TensorFlow 2.4.3, and TensorFlow 2.3.4, as these are also affected and still in supported range.

Rincian

Terbit di NVD
12 Agustus 2021
Terakhir diubah
17 Juni 2026
Status NVD
Modified
CVSS 3.1
7.8 (High), sumber NVD
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-824: Access of Uninitialized Pointer
EPSS (30 hari)
0,17% peluang dieksploitasi; lebih tinggi dari 5,5% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
google tensorflow Versi 2.3.0 hingga sebelum 2.3.4
google tensorflow Versi 2.4.0 hingga sebelum 2.4.3
google tensorflow Versi 2.5.0
google tensorflow Versi 2.6.0 rc0
google tensorflow Versi 2.6.0 rc1
google tensorflow Versi 2.6.0 rc2

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:10 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.